The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
Abstract
The 1996 Five-Factor Score (FFS) for systemic necrotizing vasculitides (polyarteritis nodosa [PAN], microscopic polyangiitis [MPA], and Churg-Strauss syndrome [CSS]) is used to evaluate prognosis at diagnosis. In the current study we revisited the FFS, this time including Wegener granulomatosis (WG).We analyzed clinical, laboratory, and immunologic manifestations present at diagnosis of systemic necrotizing vasculitides for 1108 consecutive patients registered in the French Vasculitis Study Group database. All patients met the American College of Rheumatology and Chapel Hill nomenclature criteria. Univariable and multivariable analyses yielded the 2009 FFS for the 4 systemic necrotizing vasculitides.Overall mortality was 19.8% (219/1108); mortality for each of the SNV is listed in descending order: MPA (60/218, 27.5%), PAN (86/349, 24.6%), CSS (32/230, 13.9%), and WG (41/311, 13.2%) (p < 0.001). The following factors were significantly associated with higher 5-year mortality: age >65 years, cardiac symptoms, gastrointestinal involvement, and renal insufficiency (stabilized peak creatinine ≥150 μmol/L). All were disease-specific (p < 0.001); the presence of each was accorded +1 point. Ear, nose, and throat (ENT) symptoms, affecting patients with WG and CSS, were associated with a lower relative risk of death, and their absence was scored +1 point (p < 0.001). Only renal insufficiency was retained (not proteinuria or microscopic hematuria) as impinging on outcome. According to the 2009 FFS, 5-year mortality rates for scores of 0, 1, and ≥2 were 9%, 21% (p < 0.005), and 40% (p < 0.0001), respectively.The revised FFS for the 4 systemic necrotizing vasculitides now comprises 4 factors associated with poorer prognosis and 1 with better outcome. The retained items demonstrate that visceral involvement weighs heavily on outcome. The better WG prognosis for patients with ENT manifestations, even for patients with other visceral involvement, compared with the prognosis for those without ENT manifestations, probably reflects WG phenotype heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,215
Leavitt, R. Y., Fauci, A. S., Bloch, D. A., Michel, B. A., Hunder, G. G., Arend, W. P., Calabrese, L. H., Fries, J. F., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330807 · Cited by 1,947
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
Jayne, D. R. W., Gaskin, G., Rasmussen, N., Abramowicz, D., Ferrario, F., Guillevin, L., Mirapeix, E., Savage, C. O. S., Sinico, R. A., Stegeman, C. A., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010090 · Cited by 1,125
Self-citationThe American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa
Lightfoot, R. W., Michel, B. A., Bloch, D. A., Hunder, G. G., Zvaifler, N. J., McShane, D. J., Arend, W. P., Calabrese, L. H., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330805 · Cited by 1,076
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056
Guillevin, L., Lhote, F., Gayraud, M., Cohen, P., Jarrousse, B., Lortholary, O., Thibult, N., & Casassus, P. (1996) · Medicine · doi:10.1097/00005792-199601000-00003 · Cited by 1,000
Self-citationde Groot, K., Harper, L., Jayne, D. R. W., Flores Suarez, L. F., Gregorini, G., Gross, W. L., Luqmani, R., Pusey, C. D., Rasmussen, N., Sinico, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00004 · Cited by 957
Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
Dhawan, R. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79350-2 · Cited by 674
Gayraud, M., Guillevin, L., Le Toumelin, P., Cohen, P., Lhote, F., Casassus, P., Jarrousse, B., & the French Vasculitis Study Group (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<666::aid-anr116>3.0.co;2-a · Cited by 553
Self-citationGuillevin, L., Cordier, J., Lhote, F., Cohen, P., Jarrousse, B., Royer, I., Lesavre, P., Jacquot, C., Bindi, P., Bielefeld, P., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401213 · Cited by 509
Self-citationGuillevin, L., Mahr, A., Callard, P., Godmer, P., Pagnoux, C., Leray, E., & Cohen, P. (2005) · Medicine · doi:10.1097/01.md.0000180792.80212.5e · Cited by 430
Self-citationMukhtyar, C., Flossmann, O., Hellmich, B., Bacon, P., Cid, M., Cohen-Tervaert, J. W., Gross, W. L., Guillevin, L., Jayne, D., Mahr, A., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071936 · Cited by 419
Self-citationHogan, S. L., Nachman, P. H., Wilkman, A. S., Jennette, J. C., & Falk, R. J. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7123 · Cited by 386
Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis
Klemmer, P. J., Chalermskulrat, W., Reif, M. S., Hogan, S. L., Henke, D. C., & Falk, R. J. (2003) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.015 · Cited by 360
Ribi, C., Cohen, P., Pagnoux, C., Mahr, A., Arène, J., Lauque, D., Puéchal, X., Letellier, P., Delaval, P., Cordier, J., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23198 · Cited by 335
Self-citationCohen, P., Pagnoux, C., Mahr, A., Arène, J., Mouthon, L., Le Guern, V., André, M., Gayraud, M., Jayne, D., Blöckmans, D., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22679 · Cited by 322
Self-citationGuillevin, L., Cohen, P., Mahr, A., Arène, J., Mouthon, L., Puéchal, X., Pertuiset, E., Gilson, B., Hamidou, M., Lanoux, P., et al. (2003) · Arthritis Care & Research · doi:10.1002/art.10922 · Cited by 251
Self-citationDevelopment and validation of a disease extent index for Wegener's granulomatosis.
de Groot, K., Gross, W. L., Herlyn, K., & Reinhold‐Keller, E. (2001) · PubMed · Cited by 166
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients
Charlier, C., Hénégar, C., Launay, O., Pagnoux, C., BEREZNE, A., Bienvenu, B., Cohen, P., Mouthon, L., & Guillevin, L. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088302 · Cited by 156
Self-citationOutcome of Patients With Small-Vessel Vasculitis Admitted to a Medical ICU
Khan, S. A., Subla, M. R., Behl, D., Specks, U., & Afessa, B. (2007) · CHEST Journal · doi:10.1378/chest.06-2464 · Cited by 67
Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis
Lamprecht, P., Anika, E., Mueller, A., Csernok, E., Reinhold‐Keller, E., Holl‐Ulrich, K., Feller, A. C., Bruehl, H., & Gross, W. L. (2002) · Arthritis Research & Therapy · doi:10.1186/ar610 · Cited by 43
Merkel, P. A., Seo, P., Aries, P., Neogi, T., Villa‐Forte, A., Boers, M., Cuthbertson, D. D., Felson, D. T., Hellmich, B., Hoffman, G. S., et al. (2005) · PubMed · Cited by 41
Self-citationExpression of host defense scavenger receptors in spondylarthropathy
McBeth (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200104)44:4 · Cited by 1
Cited by
Comarmond, C., Pagnoux, C., Khellaf, M., Cordier, J., Hamidou, M., Viallard, J., Maurier, F., Jouneau, S., Bienvenu, B., Puéchal, X., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37721 · Cited by 937
Self-citationKitching, A. R., Anders, H.-J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 928
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Hellmich, B., Sanchez-Alamo, B., Schirmer, J. H., Berti, A., Blockmans, D., Cid, M. C., Holle, J. U., Hollinger, N., Karadag, O., Kronbichler, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223764 · Cited by 768
Self-citationChung, S. A., Langford, C. A., Maz, M., Abril, A., Gorelik, M., Guyatt, G., Archer, A. M., Conn, D. L., Full, K. A., Grayson, P. C., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41773 · Cited by 702
Groh, M., Pagnoux, C., Baldini, C., Bel, E., Bottero, P., Cottin, V., Dalhoff, K., Dunogué, B., Gross, W., Holle, J., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.022 · Cited by 476
Self-citation
Metadata
- Authors
- Guillevin, L., Pagnoux, C., Seror, R., Mahr, A., Mouthon, L., & Toumelin, P. L.
- Venue
- Medicine
- Published
- 2011-01
- Volume
- 90
- Issue
- 1
- Pages
- 19-27
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2053251763
- Cited by
- 951
- References
- 29
- FWCI
- 21.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.